Management of ventricular tachycardia in the setting of a dedicated unit for the treatment of complex ventricular arrhythmias: Long-term outcome after ablation

Circulation

Volumn 127, Issue 13, 2013, Pages 1359-1368

  Della Bella, Paolo ^a   Baratto, Francesca ^a   Tsiachris, Dimitris ^a   Trevisi, Nicola ^a   Vergara, Pasquale ^a   Bisceglia, Caterina ^a   Petracca, Francesco ^a   Carbucicchio, Corrado ^b   Benussi, Stefano ^a   Maisano, Francesco ^a   Alfieri, Ottavio ^a   Pappalardo, Federico ^a   Zangrillo, Alberto ^a   MacCabelli, Giuseppe ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CENTRO CARDIOLOGICO MONZINO   (Italy)

Author keywords

Catheter ablation; Heart failure; Risk factors; Survival; Ventricular tachycardia

Indexed keywords

AMIODARONE;

ABLATION THERAPY; ADULT; ARTICLE; BENIGN TUMOR; BLOOD GAS ANALYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CATHETER ABLATION; CLINICAL EXAMINATION; COMORBIDITY; CONGENITAL HEART DISEASE; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE DYSPLASIA; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INTENSIVE CARE UNIT; INTERNAL ILIAC ARTERY; KIDNEY DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT COMFORT; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROPERITONEAL HEMATOMA; SINUS RHYTHM; STORAGE DISEASE; SUDDEN DEATH; SURVIVAL; SURVIVAL TIME; THORAX RADIOGRAPHY; VALVULAR HEART DISEASE;

AGED; CATHETER ABLATION; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HOSPITAL UNITS; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875929872     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.112.000872     Document Type: Article

References (19)

1. Kuck KH, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). Circulation. 2000;102:748-754
2. Conolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, Mitchell LB, Green MS, Klein GJ, O'Brien B. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable defibrillator against amiodarone. Circulation.2000;101:1297-1302
3. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II. Long-Term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation. 2010;122:1265-1271
4. Irvine J, Dorian P, Baker B, O'Brien BJ, Roberts R, Gent M, Newman D, Connolly SJ. Quality of life in the Canadian Implantable Defibrillator Study (CIDS). Am Heart J. 2002;144:282-289
5. Poole JE, Johnson GW, Hellkamp AS, Anderson J, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, Yee R, Guarnieri T, Talajic M, Wilber DJ, Fishbein DP, Packer DL, Mark DB, Lee KL, Bardy GH. Prognostic importance of defibrillator shocks in patients with heart failure. N Engl J Med. 2008;359:1009-1017
6. Anderson KP. Sudden cardiac death unresponsive to implantable defibrillator therapy: An urgent target for clinicians, industry and government. J Interv Card Electrophysiol. 2005;14:71-78
7. Connolly SJ, Dorian P, Roberts RS, Gent M, Bailin S, Fain ES, Thorpe K, Champagne J, Talajic M, Coutu B, Gronefeld GC, Hohnloser SH. Comparison of ß-blockers, amiodarone plus ß-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: The OPTIC study: A randomized trial. JAMA 2006;295:165-171
8. Carbucicchio C, Santamaria M, Trevisi N, Maccabelli G, Giraldi F, Fassini G, Riva S, Moltrasio M, Cireddu M, Veglia F, Della Bella P. Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: Short-And long-Term outcomes in a prospective single-center study. Circulation. 2008;117:462-469
9. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27:65-75
10. Carbucicchio C, Della Bella P, Fassini G, Trevisi N, Riva S, Giraldi F, Baratto F, Marenzi G, Sisillo E, Bartorelli A, Alamanni F. Percutaneous cardiopulmonary support for catheter ablation of unstable ventricular arrhythmias in high-risk patients. Herz. 2009;34:545-552
11. Reddy VY, Reynolds MR, Neuzil P, Richardson AW, Taborsky M, Jongnarangsin K, Kralovec S, Sediva L, Ruskin JN, Josephson ME. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357:2657-2665
12. Kuck KH, Schaumann A, Eckardt L, Willems S, Ventura R, Delacrée;taz E, Pitschner HF, Kautzner J, Schumacher B, Hansen PS; VTACH Study Group. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial. Lancet. 2010;375:31-40
13. Sauer WH, Zado E, Gerstenfeld EP, Marchlinski FE, Callans DJ. Incidence and predictors of mortality following ablation of ventricular tachycardia in patients with an implantable cardioverter-defibrillator. Heart Rhythm. 2010;7:9-14
14. Aliot EM, Stevenson WG, Almendral-Garrote JM, Bogun F, Calkins CH, Delacretaz E, Della Bella P, Hindricks G, Jaïs P, Josephson ME, Kautzner J, Kay GN, Kuck KH, Lerman BB, Marchlinski F, Reddy V, Schalij MJ, Schilling R, Soejima K, Wilber D. EHRA/HRS expert consensus on catheter ablation of ventricular arrhythmias: Developed in a partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Europace 2009;11:771-817
15. Calkins H, Epstein A, Packer D, Arria AM, Hummel J, Gilligan DM, Trusso J, Carlson M, Luceri R, Kopelman H, Wilber D, Wharton JM, Stevenson W; Cooled RF Multi Center Investigators Group. Catheter ablation of ventricular tachycardia in patients with structural heart disease using cooled radiofrequency energy: Results of a prospective multicenter study. J Am Coll Cardiol. 2000;35:1905-1914
16. Stevenson W, Wilber D, Natale A, Jackman WM, Marchlinski FE, Talbert T, Gonzalez MD, Worley SJ, Daoud EG, Hwang C, Schuger C, Bump TE, Jazayeri M, Tomassoni GF, Kopelman HA, Soejima K, Nakagawa H; Multicenter Thermocool VT Ablation Trial Investigators. Irrigated radiofrequency catheter ablation guided by electroanatomic mapping for recurrent ventricular tachycardia after myocardial infarction. Circulation.2008;118:2773-2782
17. Tanner H, Hindricks G, Volkmer M, Furniss S, Kühlkamp V, Lacroix D, De Chillou C, Almendral J, Caponi D, Kuck KH, Kottkamp H. Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: Results of the prospective multicenter Euro-VT-study. J Cardiovasc Electrophysiol. 2010;21:47-53
18. Mann DE, Luck JC, Griffin JC, Herre JM, Limacher MC, Magro SA, Robertson NW, Wyndham CR. Induction of clinical ventricular tachycardia using programmed stimulation: Value of third and fourth extrastimuli. Am J Cardiol. 1983;52:501-506
19. Della Bella P, De Ponti R, Uriarte JA, Tondo C, Klersy C, Carbucicchio C, Storti C, Riva S, Longobardi M. Catheter ablation and antiarrhythmic drugs for haemodynamically tolerated post-infarction ventricular tachycardia: Long-Term outcome in relation to acute electrophysiological findings. Eur Heart J. 2002;23:414-424